• Explore /
  • Poster
  • / Assessment of immunoscore and MRI tumor regression grade to predict complete pathologic response in patients with locally advanced rectal cancer: Data from phase II Averectal study.

Assessment of immunoscore and MRI tumor regression grade to predict complete pathologic response in patients with locally advanced rectal cancer: Data from phase II Averectal study.

Abstract Poster

Authors

null

Ali Shamseddine

American University of Beirut Medical Center, Beirut, Lebanon;

Ali Shamseddine , Ahmad Machmouchi , Mustafa Natout , Rim Turfa , Joseph Gergi Kattan , Sally Naji Temraz , Ayman Tawil , Mousa Elkhaldi , Omar Jaber , Rula Amarin , Tala Awabdeh , Maya Charafeddine , Monita Al Darazi , Hero Hussain

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT03503630

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 212)

DOI

10.1200/JCO.2023.41.4_suppl.212

Abstract #

212

Poster Bd #

L14

Abstract Disclosures

Similar Posters

First Author: Thierry Alcindor

First Author: Ali Shamseddine

First Author: Lisa Salvatore

Poster

2021 Gastrointestinal Cancers Symposium

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

First Author: Wen Zhang